Several reports beyond the scope of this review substantiate the important role of AKT/mTOR in cancer through genetic studies in patient populations, through the use of mouse models to dissect out the role of the pathway in specific aspects of cancer and by continued experimentation on cancer cell lines to delineate mechanistic impacts. This evidence concerns the gene AKT1 and cancer.